139 related items for PubMed ID: 3473911
1. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
Casper RC, Swann AC, Stokes PE, Chang S, Katz MM, Garver D.
Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
[Abstract] [Full Text] [Related]
2. Cortisol measures in primary major depressive disorder with hypersomnia or appetite increase.
Casper RC, Kocsis J, Dysken M, Stokes P, Croughan J, Maas J.
J Affect Disord; 1988 Mar; 15(2):131-40. PubMed ID: 2975683
[Abstract] [Full Text] [Related]
3. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL, Price LH, Charney DS, Heninger GR.
Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
[Abstract] [Full Text] [Related]
4. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
[Abstract] [Full Text] [Related]
5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[Abstract] [Full Text] [Related]
6. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
Hudson JI, Pope HG, Jonas JM, Laffer PS, Hudson MS, Melby JC.
Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
[Abstract] [Full Text] [Related]
7. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
Meador-Woodruff JH, Gurguis G, Grunhaus L, Haskett RF, Greden JF.
Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
[Abstract] [Full Text] [Related]
8. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF.
Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
[Abstract] [Full Text] [Related]
9. The influence of weight loss on the dexamethasone suppression test.
Yerevanian BI, Baciewicz GJ, Iker HP, Privitera MR.
Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
[Abstract] [Full Text] [Related]
10. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.
Roy A, Pickar D, De Jong J, Karoum F, Linnoila M.
Arch Gen Psychiatry; 1988 Sep; 45(9):849-57. PubMed ID: 3415426
[Abstract] [Full Text] [Related]
11. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
Kathol RG, Jaeckle RS, Lopez JF, Meller WH.
Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
[Abstract] [Full Text] [Related]
12. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
Gwirtsman HE, Roy-Byrne P, Gitlin MJ, Halaris A, Ahles S.
J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
[Abstract] [Full Text] [Related]
13. HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
[Abstract] [Full Text] [Related]
14. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
Acta Psychiatr Scand; 1990 Apr; 81(4):364-71. PubMed ID: 2343764
[Abstract] [Full Text] [Related]
15. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
[Abstract] [Full Text] [Related]
16. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder.
Rhebergen D, Korten NC, Penninx BW, Stek ML, van der Mast RC, Oude Voshaar R, Comijs HC.
Psychoneuroendocrinology; 2015 Jan; 51():341-50. PubMed ID: 25462906
[Abstract] [Full Text] [Related]
17. The effects of weight change on the dexamethasone suppression test in depressed and anorexic patients.
Schweitzer I, Maguire KP, Tiller JW, Gee AH, Harrison LC, Davies BM.
Br J Psychiatry; 1986 Dec; 149():751-5. PubMed ID: 3790873
[Abstract] [Full Text] [Related]
18. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J.
J Affect Disord; 1987 Dec; 12(3):219-21. PubMed ID: 2956306
[Abstract] [Full Text] [Related]
19. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
Halbreich U, Naor S, Asnis G, Gasparini F, Goldstein S, Vital-Herne J, Kang BJ.
Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
[No Abstract] [Full Text] [Related]
20. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
